Big Moving Stock keep track of the biggest moving stocks in the market.


Nasdaq: AAPL GOOG NFLX AMZN BIIB REGN IBB WYNN TSLA ALXN ILMN JAZZ CELG CHTR COST AMGN FFIV Z PCYC
Nyse: V ACT UNP IBM IVV LNKD SPG AGN GS LMT CMI TWC MMM FDX CXO PX BA CVX NOC UTX
New Highs: PSA AGN CXO MTB XEC FRT EQT HP CAT EOG SLG ZMH APH SIAL RRC HES MJN EMN SNDK TRW

The Hot Industries

Independent Oil & Gas 4
REIT - Retail 2
Oil & Gas Drilling & Exploration 2

The Hot Sectors

Basic Materials 8
Financial 4
Technology 2

AMRN Stock Chart


AMRN
Analyze

Sector:

Healthcare
Daily

Industry:

Drug Manufacturers - Other
Weekly

Employees:

185
Monthly

Website:

http://www.amarincorp.com

AMRN Amarin Corporation plc

Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases in the United States. It develops products in the areas of lipid science and therapeutic benefits of polyunsaturated fatty acids. The company markets Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. It is also developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is based in Dublin, Ireland.

favicon

Amarin Corp. and Kowa Pharmaceuticals to Begin Joint Vascepa Promotion in May

11 Apr 2014, 10:24 amAmarin Corp. PLC (NASDAQ:AMRN) stock volume was tepid Apr. 10, with just 1,595,690 shares, a third of its three-month average volume of 4,405,235 shares.
favicon

Biotech Stock Roundup: MannKind Soars on Panel Vote, Halozyme Plunges on Safety Concerns

9 Apr 2014, 9:48 amLast week saw a couple of positive FDA panel votes as well as some disappointing data on experimental drugs.
favicon

Adherex At ASCO, FDA Panel Backs CBST, DRTX, PRAN's IMAGINE Fails, SKBI Shines

31 Mar 2014, 11:23 pmShares of Durata Therapeutics Inc. (DRTX) climbed over 5 percent to $14.15 in extended trading on Monday after the company's investigational drug, Dalvance, for the treatment of adult patients with acute bacterial skin and skin structure infections won the unanimous backing of FDA panel.
favicon

3 Biotech Stocks Under $10 to Trade for Breakouts

28 Mar 2014, 1:08 pmKeep these under-$10 biotech stocks on your radar. Click to view a price quote on ADMP . Click to research the Drugs industry.        
favicon

Northwest vs Feuerstein rhubarb round 3

28 Mar 2014, 11:42 amNorthwest Biotherapeutics ( NWBO -9.9% ) takes predictable exception to The Street's Adam Feuerstein regarding his bearish comments after CEO Linda Powers' DC-Vax presentation on March 27. The company insists that the statistical significance of the phase 3 trial results increases its chances of success not decreases as Mr. Feuerstein asserts. It also disputes his opinion that the trial has been ...
favicon

Biotech Equities Technical Study -- Research on Prana Biotechnology, Amarin, United Therapeutic, and OPKO Health

28 Mar 2014, 10:42 amLONDON, March 28, 2014 /PRNewswire/ -- On Thursday, March 27, 2014, the NASDAQ Composite ended at 4,151.23, down 0.54%, the Dow Jones Industrial Average edged 0.03% lower to 16,264.23, and the S&P 500 closed at 1,849.04, down 0.19%. The losses were broad based with seven out of ten...